Drug Trial Radar · NCT06914908
Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study
Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
71
Actual
Start
May 12, 2025
Primary completion
Feb 22, 2029
Study completion Feb 22, 2029
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Apr 7, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately controlled CRSwNP who have completed a previous lunsekimig CRSwNP clinical study (also referred to as the parent study ACT18207). The study duration will be up to approximately 148 weeks per participant, including 144 weeks of treatment period and 4 weeks of follow-up.
Conditions
- Chronic Rhinosinusitis With Nasal Polyps
Interventions
LunsekimigDrug
* Pharmaceutical form: solution for injection * Route of administration: subcutaneous
Mometasone furoate nasal spray (MFNS)Drug
* Pharmaceutical form: Solution for administration via spray pump * Route of administration: intranasal spray
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of participants with treatment-emergent adverse events (TEAEs) including adverse events of special interest (AESI), and serious adverse events (SAEs)Time frame: From baseline to Week 148
Locations
24 sites in 6 countries. Site status is shown where the registry gives one.
Orso Health- Site Number : 8400005
La Jolla, California
Capital Allergy & Respiratory Disease Center- Site Number : 8400003
Roseville, California
Treasure Valley Medical Research- Site Number : 8400002
Boise, Idaho
Essential Medical Research- Site Number : 8400020
Tulsa, Oklahoma
Pharmaceutical Research & Consulting- Site Number : 8400004
Dallas, Texas
The University of Texas Health Science Center- Site Number : 8400017
Houston, Texas
ENT Associates of Texas - McKinney- Site Number : 8400014
McKinney, Texas
Alamo ENT Associates- Site Number : 8400001
San Antonio, Texas
Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400008
Norfolk, Virginia
Investigational Site Number : 0320001
Buenos Aires, Argentina
Investigational Site Number : 0320003
Mendoza, Argentina
Investigational Site Number : 0320002
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0560002
Ghent, Belgium
Investigational Site Number : 0560001
Leuven, Belgium
Investigational Site Number : 1000001
Sofia, Bulgaria
Investigational Site Number : 6160004
Poznan, Greater Poland Voivodeship, Poland
Investigational Site Number : 6160002
Krakow, Lesser Poland Voivodeship, Poland
Investigational Site Number : 6160007
Wroclaw, Lower Silesian Voivodeship, Poland
Investigational Site Number : 6160001
Warsaw, Masovian Voivodeship, Poland
Investigational Site Number : 6160005
Warsaw, Masovian Voivodeship, Poland
Investigational Site Number : 6160003
Katowice, Silesian Voivodeship, Poland
Investigational Site Number : 8260003
Manchester, United Kingdom
Investigational Site Number : 8260001
Newcastle upon Tyne, United Kingdom
Investigational Site Number : 8260004
Gloucester, Gloucestershire, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.